External validators converging: multiple independent outside parties have recently, concretely endorsed the company with
The model's full reasoning — Q2 2017 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了多个独立外部方最近采取了具体行动(如投资、批准、合作等),并且管理层将这些行动视为对公司轨迹的验证,且这些行动的影响尚未完全反映在报告结果中。 在记录中,管理层提到了: 1. 与Bristol-Myers Squibb的许可协议(BIIB092),这是外部方(BMS)提供资产,但这是公司购买,不是外部方投资。 2. 收购Remedy Pharmaceuticals的资产(BIIB093),也是公司购买。 3. 与Siemens合作开发MRI工具,但这是合作,不是具体行动。 4. 与Ionis Pharmaceuticals合作(BIIB067),但这是合作。 5. 与Eisai合作(BAN2401),但这是合作。 6. 与Penn合作基因治疗,但未提及具体行动。 7. 与Brammer Bio合作制造,但未提及具体行动。 8. 与Cleveland Clinic合作开发MS Performance Test,但未提及具体行动。 9. 与Samsung Bioepis的合资企业,但未提及具体行动。 10. 与多个支付方签订价值合同,但这是公司自己的行动。 管理层提到了外部方如BMS、Remedy、Siemens、Ionis、Eisai、Penn、Brammer Bio等,但这些都是合作或收购,不是外部方“put something real of its own behind this company”的独立行动。例如,BMS许可资产给Biogen,是Biogen支付费用,不是BMS投资。收购Remedy也是Biogen支付。这些不是外部方对公司的背书。 此外,管理层提到了监管批准(如SPINRAZA在欧洲、日本、加拿大获批),但这是监管机构批准,不是外部方投资。但批准是外部方(监管机构)的行动,但这是常规审批,不是“put something real of its own”吗?批准是官方认可,但通常不算作投资或承诺。而且管理层没有将多个批准联系起来作为验证。 管理层还提到了“value-based contracts”与四个支付方,但这是公司自己的商业行动,不是外部方主动投资。 因此,没有看到至少两个独立外部方采取具体行动(如投资、大额订单、指定等)来背书公司。所有提到的都是合作或公司自己的收购。 所以答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MMLP | Martin Midstream Partners L.P. | Q2 2024 | 2024-07-18 | B |
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| ICCM | IceCure Medical Ltd | Q3 2023 | 2023-11-15 | D |
| AIRG | Airgain, Inc. | Q3 2023 | 2023-11-09 | F |
| EFXT | Enerflex Ltd. | Q3 2023 | 2023-11-09 | C+ |
| NVAX | Novavax, Inc. | Q3 2023 | 2023-11-09 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| APAM | Artisan Partners Asset Management Inc. | Q3 2023 | 2023-11-01 | C+ |
| DXLG | Destination XL Group, Inc. | Q2 2023 | 2023-08-24 | D |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| SITM | SiTime Corporation | Q2 2023 | 2023-08-02 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| ARWR | Arrowhead Pharmaceuticals, Inc. | Q4 2022 | 2022-11-28 | D |
| CUE | Cue Biopharma, Inc. | Q3 2022 | 2022-11-14 | D |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| ICL | ICL Group Ltd | Q3 2022 | 2022-11-09 | B+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| AWRE | Aware, Inc. | Q3 2022 | 2022-10-30 | F |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| DM | Desktop Metal, Inc. | Q2 2022 | 2022-08-08 | F |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| CDXC | ChromaDex Corporation | Q4 2021 | 2022-03-09 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| ALHC | Alignment Healthcare, Inc. | Q3 2021 | 2021-11-06 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| WMB | The Williams Companies, Inc. | Q3 2021 | 2021-11-02 | B |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| UFI | Unifi, Inc. | Q4 2021 | 2021-08-07 | B |
| CRS | Carpenter Technology Corporation | Q4 2021 | 2021-08-01 | A |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| HPE | Hewlett Packard Enterprise Company | Q2 2018 | 2018-05-22 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| EPAM | EPAM Systems, Inc. | Q4 2017 | 2018-02-16 | B |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| UNH | UnitedHealth Group Incorporated | Q4 2017 | 2018-01-16 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| MXL | MaxLinear, Inc. | Q2 2017 | 2017-08-08 | C+ |
| CNS | Cohen & Steers, Inc. | Q2 2017 | 2017-07-20 | B |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| NTCT | NetScout Systems, Inc. | Q2 2017 | 2016-10-27 | D |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| GES | Guess?, Inc. | Q1 2017 | 2016-05-25 | F |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| SPR | Spirit AeroSystems Holdings, Inc. | Q1 2016 | 2016-04-29 | D |
| ACCO | ACCO Brands Corporation | Q1 2016 | 2016-04-27 | B+ |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
| ENLC | EnLink Midstream, LLC | Q4 2015 | 2016-02-17 | C+ |
| JJSF | J&J Snack Foods Corp. | Q1 2016 | 2016-01-26 | C |
DUOT · Q4 2023 → YESThe question is: Does management describe that MORE THAN ONE INDEPENDENT OUTSIDE PARTY has RECENTLY put something real of its own behind this company — money, orders, capacity, reputation, approval, o...NO The transcript mentions new AI subscription and support services contracts with two major railroads, which are concrete recent actions by two independent outside parties. However, management describes these as "just the beginning," indicating that the business implied is early relative to the company's reported size. This meets the criteria for YES under the specific conditions provided but the overall context of poor financials and the need for capital infusion suggests the actions may not fully align with the "validating a trajectory whose contribution is still mostly ahead" aspect in a way that overrides the NO criteria for rescue financing or balance-sheet repair. The patent grant is an approval but not a party putting money or orders behind the company in the required sense. Partnerships with Dell and NVIDIA are strengthened but not new concrete actions costing to reverse. Thus, the answer is NO.
TENB · Q2 2021 → YESThe question is about whether management describes more than one independent outside party recently putting something real behind the company, and treating this as validating a trajectory still mostly...YES The transcript shows management describing multiple independent outside parties taking concrete recent actions that validate the company's trajectory as still early relative to reported results. Specifically, NIST selected Tenable as one of 18 technologies for its Zero Trust initiative, granting formal approval and admission. Separately, the company entered a $375 million credit agreement with lenders to support growth, providing capital backing. These actions—approval and investment—are treated by management as endorsements of the business's early-stage potential, with references to ongoing deployments and pipeline activity in areas like OT and AD that exceed the current reported size. The parties are independent, and the actions are recent and in motion rather than reflective of fully realized results.
CRGO · Q1 2024 → YESThe question is: Does management describe that MORE THAN ONE INDEPENDENT OUTSIDE PARTY has RECENTLY put something real of its own behind this company — money, orders, capacity, reputation, approval, o...NO The transcript describes partnerships or expansions with United Airlines, Delta Cargo, Singapore Airlines, and Fits Cargo, but these are presented as ongoing or expanding relationships rather than new, concrete recent actions from multiple independent parties that validate an early-stage trajectory. The United Airlines example is a specific commitment to build a portal, yet the 49 carrier sellers and new additions are framed as rollouts already reflected in results, with pipeline mentions indicating future activity. Management connects these to growth but does not clearly treat the convergence as validating a trajectory mostly ahead of reported results in a way that meets the criteria for multiple independent endorsements with costly commitments.